COVID-19 and Gestational Diabetes: The Role of Nutrition and Pharmacological Intervention in Preventing Adverse Outcomes
- PMID: 36079820
- PMCID: PMC9460671
- DOI: 10.3390/nu14173562
COVID-19 and Gestational Diabetes: The Role of Nutrition and Pharmacological Intervention in Preventing Adverse Outcomes
Abstract
Pregnant women with GDM affected by COVID-19 seem to be at higher risk of adverse maternal and neonatal outcomes, especially those with overweight or obesity. Good glycemic control seems to be the most effective measure in reducing the risk of GDM and severe COVID-19. For such purposes, the Mediterranean diet, micronutrient supplementation, and physical activity are considered the first line of treatment. Failure to achieve glycemic control leads to the use of insulin, and this clinical scenario has been shown to be associated with an increased risk of adverse maternal and neonatal outcomes. In this review, we explore the current evidence pertaining to the pathogenesis of SARS-CoV-2 leading to the main complications caused by COVID-19 in patients with GDM. We also discuss the incidence of complications caused by COVID-19 in pregnant women with GDM according to their treatment.
Keywords: COVID-19; SARS-CoV-2; adverse maternal and neonatal outcomes; gestational diabetes; insulin; metformin; nutrition; physical activity.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
How Do Maternal Gestational Diabetes and Other Concomitant Maternal Factors Determine the Perinatal Outcomes of Pregnancy?-A Retrospective Analysis.Nutrients. 2025 Jan 2;17(1):177. doi: 10.3390/nu17010177. Nutrients. 2025. PMID: 39796611 Free PMC article.
-
Metformin in overweight and obese women with gestational diabetes: a propensity score-matched study.Endocrine. 2019 Nov;66(2):192-200. doi: 10.1007/s12020-019-02043-3. Epub 2019 Aug 11. Endocrine. 2019. PMID: 31401725
-
WeChat-assisted dietary and exercise intervention for prevention of gestational diabetes mellitus in overweight/obese pregnant women: a two-arm randomized clinical trial.Arch Gynecol Obstet. 2021 Sep;304(3):609-618. doi: 10.1007/s00404-021-05984-1. Epub 2021 Feb 11. Arch Gynecol Obstet. 2021. PMID: 33570656 Clinical Trial.
-
[Gestational Diabetes Mellitus].Vnitr Lek. 2016 Fall;62(11 Suppl 4):S52-61. Vnitr Lek. 2016. PMID: 27921426 Review. Czech.
-
The effects of vitamin D supplementation on glycemic control and maternal-neonatal outcomes in women with established gestational diabetes mellitus: A systematic review and meta-analysis.Clin Nutr. 2021 May;40(5):3148-3157. doi: 10.1016/j.clnu.2020.12.016. Epub 2020 Dec 21. Clin Nutr. 2021. PMID: 33386179
Cited by
-
Impact of Obesity and Diabetes in Pregnant Women on Their Immunity and Vaccination.Vaccines (Basel). 2023 Jul 17;11(7):1247. doi: 10.3390/vaccines11071247. Vaccines (Basel). 2023. PMID: 37515062 Free PMC article. Review.
-
Clinical characteristic and outcomes of pregnant women with COVID-19: The PROUDEST prospective cohort study.PLoS One. 2025 Jul 3;20(7):e0327174. doi: 10.1371/journal.pone.0327174. eCollection 2025. PLoS One. 2025. PMID: 40608806 Free PMC article.
References
-
- Allotey J., Stallings E., Bonet M., Yap M., Chatterjee S., Kew T., Debenham L., Llavall A.C., Dixit A., Zhou D., et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis. BMJ. 2020;370:m3320. doi: 10.1136/bmj.m3320. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous